$115-140k
More information about location
4 days a week in office
AI powered neural intent platform
Open for applications
AI powered neural intent platform
21-100 employees
Open for applications
$115-140k
More information about location
4 days a week in office
21-100 employees
To translate data generated by the body's natural physiological electricity into machine-interpretable events.
Jump to section
To translate data generated by the body's natural physiological electricity into machine-interpretable events.
Born from the personal frustration felt by co-founder Dexter Ang, whose mother suffered from ALS, Pison was created to help improve the quality of life for patients who lose the ability to speak, write, and gesture while battling the nervous system disease.
The company provides technology that allows ALS patients to interact with wearable devices and control the physical world through thinking alone. With development partners including Google, Microsoft, and Samsung, the system captures neuromuscular signals on the surface of the skin and combines them with machine learning and AI to interpret how people intend to move their hands.
Pison has raised money both through grants and traditional investment rounds, closing its Series A in 2021. This funding is being used to develop multiple market-ready products, and to increase the company’s headcount.
Kirsty
Company Specialist at Welcome to the Jungle
Jun 2022
$0.5m
GRANT
Mar 2021
$7m
SERIES A
Dexter Ang
(Executive Chairman)After working as an Advanced Study fellow at MIT, they became a Senior Trader at Jump Trading, an algorithmic trading platform.
David Cipoletta
(CTO)Graduated from The University of Rhode Island with a Masters in Electrical and Electronics Engineering. Former Robotics Engineer for Charles River Analytics.
Software Engineering
Marketing
Other Engineering
Sales & Account Management